Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation
暂无分享,去创建一个
R J Mark | M. Mattson | J. Geddes | K. Uchida | M P Mattson | K Uchida | Z. Pang | Z Pang | J W Geddes | R. Mark
[1] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[2] A. Young,et al. Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.
[3] A. Novelli,et al. Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.
[4] M. Mattson,et al. Basic FGF, NGF, and IGFs Protect Hippocampal and Cortical Neurons against Iron-Induced Degeneration , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] W. Markesbery,et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. D. Ehmann,et al. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.
[7] R. Bucala,et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[8] D. Butterfield,et al. Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures , 1996, Journal of neurochemistry.
[9] R Luft,et al. The development of mitochondrial medicine. , 1995, Biochimica et biophysica acta.
[10] G. Benzi,et al. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. , 1995, Free radical biology & medicine.
[11] M. Mattson,et al. Anticonvulsants attenuate amyloid β-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology , 1995, Neurobiology of Aging.
[12] D. Selkoe. The molecular pathology of Alzheimer's disease , 1991, Neuron.
[13] T. Montine,et al. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. , 1996, The American journal of pathology.
[14] M. Mattson,et al. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes , 1997, Neuroscience.
[15] I. Simpson,et al. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. , 1996, The Biochemical journal.
[16] C. Cotman,et al. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.
[17] Takesue Yoshiki,et al. Effect of phloretin on na+-dependent d-glucose uptake by intestinal brush border membrane vesicles , 1983 .
[18] R. Rydel,et al. Amyloid β‐Mediated Oxidative and Metabolic Stress in Rat Cortical Neurons: No Direct Evidence for a Role for H2O2 Generation , 1996, Journal of neurochemistry.
[19] F. Crawford,et al. Genetic and molecular advances in Alzheimer's disease. , 1993, Trends in neurosciences.
[20] M. Brines,et al. The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus , 1995, Neuroscience Letters.
[21] J. Blass. Metabolic alterations common to neural and non‐neural cells in alzheimer's disease , 1993, Hippocampus.
[22] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] H. Thaler,et al. Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease. , 1990, The American journal of pathology.
[24] M. Beal,et al. Bioenergetic and oxidative stress in neurodegenerative diseases. , 1995, Life sciences.
[25] M. Mattson,et al. Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[26] M. Mattson,et al. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Sapolsky,et al. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. , 1990, Neuroendocrinology.
[28] Richard S. J. Frackowiak,et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease , 1995, Neuroscience Letters.
[29] M. Mattson,et al. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF , 1993, Brain Research.
[30] G. Perry,et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Hyman,et al. Functional Alterations in Alzheimer's Disease: Decreased Glucose Transporter 3 Immunoreactivity in the Perforant Pathway Terminal Zone , 1995, Journal of neuropathology and experimental neurology.
[32] M. Mattson,et al. Metyrapone, an Inhibitor of Glucocorticoid Production, Reduces Brain Injury Induced by Focal and Global Ischemia and Seizures , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] M. Mattson,et al. β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .
[34] M. Mullan,et al. Genetics and molecular advances in Alzheimer's disease , 1993, Trends in Neurosciences.
[35] M. Alaiz,et al. Modification of histidine residues by 4,5-epoxy-2-alkenals. , 1999, Chemical Research in Toxicology.
[36] S. Younkin,et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.
[37] M. Mattson,et al. Growth Factors Prevent Mitochondrial Dysfunction, Loss of Calcium Homeostasis, and Cell Injury, but Not ATP Depletion in Hippocampal Neurons Deprived of Glucose , 1993, Experimental Neurology.
[38] I. Simpson,et al. Modulation of Expression of Glucose Transporters GLUT3 and GLUT1 by Potassium and N-Methyl-d-aspartate in Cultured Cerebellar Granule Neurons , 1994, Molecular and Cellular Neuroscience.
[39] D E Kuhl,et al. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] S. Younkin,et al. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.
[41] M. Mattson,et al. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF , 1992, Experimental Neurology.
[42] J. Pettegrew,et al. Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study , 1994, Neurobiology of Aging.
[43] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[44] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[45] R N Kalaria,et al. Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.
[46] M. Mattson,et al. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. , 1994, Experimental neurology.
[47] Mark P. Mattson,et al. β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.
[48] M. Mattson,et al. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor , 1996 .
[49] M. Mattson,et al. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. , 1995, Methods in cell biology.
[50] M. Mattson,et al. Secreted Forms of β-Amyloid Precursor Protein Protect Hippocampal Neurons against Amyloid β-Peptide-Induced Oxidative Injury , 1994, Experimental Neurology.
[51] N. Sims. Altered glucose metabolism in Alzheimer's disease , 1990, Annals of neurology.
[52] E. Stadtman,et al. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[53] Carl W. Cotman,et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] B. Yankner,et al. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.
[55] D. Selkoe,et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.
[56] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[57] W. Honer,et al. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.
[58] M. Mattson,et al. Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. , 1996, Brain research. Molecular brain research.
[59] E. Stadtman,et al. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[60] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[61] M. Mattson,et al. A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.
[62] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[63] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[64] P. Calabresi,et al. Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPase , 1995, The European journal of neuroscience.
[65] F. V. van Kuijk,et al. 4-hydroxynonenal inhibits Na(+)-K(+)-ATPase. , 1996, Free radical biology & medicine.
[66] M. Mattson. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons , 1990, Neuron.
[67] P. May,et al. β-amyloid peptide in vitro toxicity: Lot-to-lot variability , 1992, Neurobiology of Aging.
[68] W. Jagust,et al. Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[69] M. Mattson,et al. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[70] M. Mattson. Untangling the pathophysio-chemistry of β-amyloid , 1995, Nature Structural Biology.
[71] L. Iversen,et al. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[72] B. Yankner. Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.
[73] C. Cotman,et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[74] Brian J Cummings,et al. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity , 1995, The Lancet.
[75] M. Mattson,et al. Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.